News
MedPage Today on MSN1d
Nasal Powder for Acute Migraine Gets FDA NodThe FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback